PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001140361-24-046891
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$10.73M | -$10.85M | -$7.42M | -$6.96M |
| EPS Diluted | -$0.29 | -$0.35 | -$0.26 | -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
